Dr. Spyridon Marinopoulos is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include general internal medicine. Dr. Marinopoulos serves as the director of University Health Services at Johns Hopkins. Dr. Marinopoulos completed his undergraduate studies with a degree in chemistry from the University of Chicago. He received his M.D. degree from the University of Chicago Pritzker School of Medicine and his M.B.A. from the University of Chicago Graduate School of Business, with a concentration in health administration and policy. He received his internal medicine training at New York Presbyterian Hospital Weill Cornell Medical Center. After two years in private practice, Dr. Marinopoulos joined the full-time faculty in the Division of General Internal Medicine at Johns Hopkins in 2001. His research interests include evidence-based medicine. MD, The University of Chicago Pritzker School of Medicine (1996)

Evidence-based medicine

Dr. Marinopoulos has published in the area of evidence-based medicine and has interests in the areas of university health and health care administration.

Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M. "Low protein expression of MET in ER-positive and HER2-positive breast cancer." Anticancer Res. 2014 Mar;34(3):1227-31. Finkelstein J, Knight A, Marinopoulos S, Gibbons MC, Berger Z, Aboumatar H, Wilson RF, Lau BD, Sharma R, Bass EB. "Enabling patient-centered care through health information technology." Evid Rep Technol Assess (Full Rep). 2012 Jun;(206):1-1531. Review. Karatapanis S, Skorda L, Marinopoulos S, Papastergiou V, Drogosi M, Lisgos P, Antsaklis A. Higher rates of chronic hepatitis B infection and low vaccination-induced protection rates among parturients escaping HBsAg prenatal testing in Greece: a 2-year prospective study. Eur J Gastroenterol Hepatol. 2012 Aug;24(8):878-83. doi: 10.1097/MEG.0b013e328354834f. PMID: 22588307 Bennett WL, Wilson LM, Bolen S, Maruthur N, Singh S, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Nicholson WK, Block L, Odelola O, Dalal DS, Ogbeche GE, Chandrasekhar A, Hutfless S, Bass EB, Segal JB. Oral Diabetes Medications for Adults With Type 2 Diabetes: An Update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Mar. PMID: 21735563 Papantoniou V, Valsamaki P, Sotiropoulou E, Tsaroucha A, Tsiouris S, Sotiropoulou M, Marinopoulos S, Kounadi E, Karianos T, Fothiadaki A, Archontaki A, Syrgiannis K, Ptohis N, Makris N, Limouris G, Antsaklis A. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia. Mol Imaging. 2011 Oct;10(5):370-6. doi: 10.2310/7290.2010.00056. Epub 2011 Apr 26. PMID: 21521552 Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Block L, Nicholson WK, Hutfless S, Bass EB, Bolen S. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011 May 3;154(9):602-13. doi: 10.7326/0003-4819-154-9-201105030-00336. Epub 2011 Mar 14. Review. Erratum in: Ann Intern Med. 2011 Jul 5;155(1):67-8. PMID: 21403054